COMP <GO>
CRDF vs ATRA // FORWARD P/E MULTIPLE
Cardiff Oncology Inc. (NASDAQ) VS. Atara Biotherapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CRDF 1
— ATRA 6
■ METRIC PARITY
LAST: $0.84 (-5.09%) • MKT CAP: $69.2M
forward-pe
—
LAST: $8.48 (+5.87%) • MKT CAP: $80.4M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRDF VS. ATRA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRDF | ATRA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 85.00% | -120.00 | ATRA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 29.70% | -89.70 | ATRA | /operating-margins <GO> |
| Net Profit Margin | -7.70% | 27.10% | -34.80 | ATRA | /net-margins <GO> |
| Revenue Growth (YoY) | -13.20% | -6.30% | -6.90 | ATRA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 3/9 | -2.00 | ATRA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.9 | 37.5 | +1.40 | CRDF | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $69.2M | $80.4M | -$11.2M | ATRA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRDF REV | ATRA REV | CRDF GROSS % | ATRA GROSS % | CRDF FCF | ATRA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $593.0K | $120.8M | — | — | -$38.0M | -$50.9M |
| FY 2024 | $683.0K | $128.9M | — | — | -$37.8M | -$69.0M |
| FY 2023 | $488.0K | $8.6M | — | — | -$30.9M | -$193.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRDF // BETA —
ATRA // BETA —